Add BrightSurf on Google Email

MD Anderson and AmMax Bio announce agreements to advance development of AMB-066 in colorectal cancer patients with minimal residual disease

The collaboration aims to evaluate the potential of AMB-066 as a first-in-class treatment option for patients with colorectal cancer and minimal residual disease. MD Anderson researchers have identified a potential opportunity for AMB-066 to effectively treat MRD-positive CRC, based on robust preclinical data.

Common food poison toxin speeds colon cancer spread

A study led by UF Health Cancer Center researchers found that a toxin in the bacteria Campylobacter jejuni accelerates the spread of colorectal tumors. The findings could lead to new tools for detecting metastatic colorectal cancer early, ultimately helping determine patients who need more aggressive treatments.

SourceUniversity of Florida·JournalCell Host & Microbe·TypeExperimental study·DateDec 6, 2024

Deadly diets driving digestive diseases

Researchers urge people to improve their eating habits to reduce the risk of bowel cancer, citing evidence that high-fibre foods promote healthy gut bacteria. Studies found a link between poor diet choices and digestive cancers, highlighting the importance of diets rich in whole grains, vegetables, fruits, and legumes.

SourceFlinders University·JournalEuropean Journal of Nutrition·TypeData/statistical analysis·DateDec 1, 2024

Home testing kits and coordinated outreach substantially improve colorectal cancer screening rates

A new study shows that mailing at-home fecal immunochemical testing kits and providing coordinated follow-up led to a tripling of screening completion rates compared to usual care. The intervention increased screening rates by 30% within six months and 34.6% by 12 months.

SourceUniversity of North Carolina Health Care·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateNov 25, 2024

The tissue and circulating cell-free DNA-derived genetic landscape of pre-malignant colorectal lesions and its application for early diagnosis of colorectal cancer

Researchers sequenced tissue and plasma samples from patients with conventional CRAs to identify genetic alterations. They found that a small proportion of samples successfully detected tissue-origin variants within matched cfDNA. The study also explored the genomic characteristics and progression of cancer from CRA to CRC-I, highlight...

Cancer genetic risk assessment guidelines expand to meet growing understanding of hereditary risk

The National Comprehensive Cancer Network has updated its guidelines for genetic/familial high-risk assessment, incorporating the latest scientific research and expert recommendations to enhance screening practices and treatment options. The expanded guidelines cover various cancer types and provide guidance on genetic testing, heredit...

Bowel cancer breakthrough

Researchers identified three long noncoding RNAs associated with worse outcomes in colorectal cancer patients, potentially serving as prognostic markers. The study's findings could enable doctors to separate high-risk patients from those at low risk of disease recurrence, leading to more effective treatment strategies.

SourceUniversity of Otago·Journalnpj Precision Oncology·DateOct 29, 2024

NTU Singapore scientists develop grain-sized soft robots controlled by magnetic fields for targeted drug delivery

Researchers developed grain-sized soft robots that can transport up to four different drugs, release them in reprogrammable orders and doses, and navigate complex environments inside the human body. The robots' precision functions have the potential to significantly improve therapeutic outcomes while minimizing side effects.

SourceNanyang Technological University·JournalAdvanced Materials·TypeExperimental study·DateOct 24, 2024

A mushroom for colorectal cancer therapy

Researchers discovered a previously unknown class of compounds in the fungus Bipolaris victoriae S27 that effectively kill colorectal cancer cells. The most effective compound, bipoterpride No. 2, targets the DCTPP1 enzyme and shows promise as a potential new treatment option.

SourceWiley·JournalAngewandte Chemie International Edition·TypeExperimental study·DateOct 17, 2024

Preoperative prediction of mesenteric lymph node metastasis in colorectal cancer using machine learning with CT-based data

Researchers developed a machine learning model to predict mesenteric lymph node metastasis preoperatively in colorectal cancer patients. The XGB-based model achieved high accuracy, identifying key predictors such as perineural invasion and hematocrit levels.

Researchers receive grant to boost colorectal cancer screening follow-up in underserved communities

A new study aims to increase follow-up care for patients who receive abnormal stool-based fecal immunochemical tests, focusing on improving coordination between primary and specialty clinics. The goal is to improve colorectal cancer screening processes in underserved populations, increasing survival and reducing mortality.

More clarity on hereditary colorectal cancer

A large proportion of gene variants previously classified as 'variants of uncertain significance' (VUS) have been reclassified as benign, according to a study published in the American Journal of Human Genetics. This reduces the total number of VUS by 37%, providing relief for carriers worldwide.

SourceUniversitatsklinikum Bonn·JournalAmerican Journal of Human Genetics·DateOct 1, 2024

Long-course radiotherapy is better than short-course for organ preservation in rectal cancer

A new study published in Annals of Oncology found that long-course radiotherapy is safer and more effective than short-course radiotherapy for preserving organs in rectal cancer patients. The treatment was shown to prevent regrowth of the primary tumour, but had similar overall survival rates.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·TypeObservational study·DateSep 11, 2024

New study in JNCCN supports chemotherapy option that reduces side effects for people with gastrointestinal cancers

Researchers found that omitting the bolus-specific 5-fluorouracil (5-FU) portion from common chemotherapy regimens improves tolerability without sacrificing treatment effectiveness. The study of 11,765 patients shows no decrease in overall survival but a notable reduction in cytopenias.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·DateSep 5, 2024

Scientists discover how the body's killer cells attack cancer

Researchers have found that natural killer cells instinctively recognize and attack the XPO1 protein, which drives cancer growth. By targeting this protein, scientists may be able to activate more killer cells to destroy cancer cells. The study suggests that this approach could lead to personalized cancer treatment with less side effects.

SourceUniversity of Southampton·JournalScience Advances·TypeRandomized controlled/clinical trial·DateAug 28, 2024

Promising treatment for rectal cancer confirmed in major study

A new treatment approach has been confirmed effective in a major study, showing that locally advanced rectal cancer patients can experience complete tumour disappearance without needing surgery. This method reduces the risk of recurrence and preserves normal bowel function, offering a promising alternative to traditional treatments.

SourceUppsala University·JournalEClinicalMedicine·TypeObservational study·DateAug 22, 2024

Offering women further screening opportunities when they visit healthcare providers for breast cancer screening may significantly increase their participation and enable early diagnosis of other cancers, per clinical trial of more than 27,000 in Denmark

A clinical trial in Denmark found that offering women further screening opportunities during breast cancer screenings significantly increased their participation and enabled early diagnosis of other cancers. The study used a cluster-randomized crossover design and involved over 27,000 participants.

SourcePLOS·JournalPLOS Medicine·TypeObservational study·DateAug 13, 2024

Study finds regular aspirin use associated with greatest reduction in colorectal cancer among those most at risk

A study published in JAMA Oncology found that regular aspirin use significantly lowers the risk of colorectal cancer in individuals with higher lifestyle-related risk factors. The benefits were most pronounced among those with unhealthiest lifestyles, where treating 78 patients with aspirin would prevent one case of colorectal cancer o...

SourceMass General Brigham·JournalJAMA Oncology·TypeObservational study·DateAug 1, 2024